Atara Biotherapeutics Inc (ATRA)

Atara Biotherapeutics Inc (ATRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $96M; returns 1 day -8.9%, 1 week -6.4%, 1 year -39.2%.

Atara Biotherapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing transformative allogeneic T-cell immunotherapies for patients with cancer and autoimmune diseases.

Groups ATRA belongs to

• Biotechnology
• Biopharmaceutical
• Immunotherapy
• Clinical Stage Biopharma
• Clinical Stage
• Healthcare
• Life Sciences
• Oncology
• Cancer Therapeutics
• Autoimmune Diseases

ATRA financial model: income statement, cash flow and balance sheet